Poster Session:
129. Experimental Mycology
Sunday, October 26, 2008: 12:15 PM-1:15 PM
Room: Hall C

Presentations:

12:15 PM
Aerosolized Voriconazole (VRC) as Prophylaxis against Invasive Pulmonary Aspergillosis (IPA) due to Aspergillus fumigatus
Justin Tolman

; Laura Najvar, BS

; Nathan Wiederhold, PharmD

; Robert Williams, PhD

; Rosie Bocanegra

; Thomas Patterson, MD, FIDSA

; Jacqueline Coalson

; Jason McConville

; John Graybill, MD


12:15 PM

12:15 PM
A Murine Model of Myocutaneous Invasive Aspergillosis
Dimitrios Kontoyiannis, MD, ScD, FACP, FIDSA

; Konstantinos Leventakos, MD

; Ronen Ben-Ami, MD

; Russel Lewis, PharmD


12:15 PM

12:15 PM
Development of a Murine Model of Cryptococcus gattii Meningitis
Destiny Molina

; George Thompson, MD

; John Graybill, MD

; Laura Najvar, BS

; Marcos Olivo

; Nathan Wiederhold, PharmD

; Rosie Bocanegra

; Thomas Patterson, MD, FIDSA


12:15 PM
Comparative Efficacy of Lipid-Complexed (ABLC) and Liposomal (AmBi) Amphotericin B against Coccidioidal Meningitis in Rabbits
Ann-Jay Tong, BA

; David Stevens, MD

; Javier Capilla, PhD

; Karl Clemons, PhD

; Marife Martinez, BS

; Raymond Sobel, MD


12:15 PM
In Vivo Efficacy of Posaconazole Against Laboratory-Selected Voriconazole-Resistant Aspergillus fumigatus in a Neutropenic Murine Pulmonary Aspergillosis Model
Elias Manavathu, PhD

; George Alangaden, MD

; Jessica Cutright, B Sc

; Pranatharthi Chandrasekar, MD

; Suganthini Krishnan-Natesan, MD


12:15 PM
Virulence of Clinical Aspergillus fumigatus Isolates with Mutations in the Cyp51A is not Reduced
Eleftheria Mavridou

; Johan Mouton, MD, PhD

; Paul Verweij, MD PhD

; W Melchers, PhD


12:15 PM
Comparison of Caspofungin (CAS) and Anidulafungin (ANID) Activity Against Echinocandin-susceptible and -resistant A. Fumigatus in a Neutropenic Murine Model of Invasive Pulmonary Aspergillosis (IPA)
Dimitrios Kontoyiannis, MD, ScD, FACP, FIDSA

; Guangling Liao, PhD

; Jingguo Hou, PhD

; Randall Prince, PharmD

; Russell Lewis, PharmD


12:15 PM
Factors Affecting Sputum Conversion Time in Pulmonary Tuberculosis
Ali Somily, MD , FRCPC, D(ABMM)

; Dennis Kunimoto, MD

; Greg Tyrrell, PhD


12:15 PM
A Novel Model of Rat Invasive Pulmonary Aspergillosis Suitable for Monitoring Disease Progress Using Surrogate Markers
Andrew Sharp, BSc

; Arvindkumar Parmar

; David Denning, FRCP, FIDSA

; Jayesh Majithiya, PhD

; Peter Warn, PhD

; Raghdaa Shrief


12:15 PM
Comparison of Surrogate Markers Suitable for Quantification of Fungal Burden in a Novel Rat Model of Invasive Pulmonary Aspergillosis
Andrew Sharp, BSc

; Arvindkumar Parmar

; David Denning, FRCP, FIDSA

; Jayesh Majithiya, PhD

; Peter Warn, PhD

; Raghdaa Shrief


12:15 PM
A Comparative Study of the In Vivo Efficacy of Anidulafungin, Caspofungin and Fluconazole on the Early Stage of Infection in a Neutropenic Murine Disseminated Candidiasis Infection Model
Elias Manavathu, PhD

; George Alangaden, MD

; Jessica Cutright, B Sc

; Pranatharthi Chandrasekar, MD

; Sanjay Revankar, M D

; Suganthini Krishnan-Natesan, MD


12:15 PM
Evaluation of a Non-Neutropenic Murine Model of Invasive Pulmonary Aspergillosis (IPA) Following Aerosolized Inoculation
Destiny Molina

; John Graybill, MD

; Laura Najvar, BS

; Marcos Olivo

; Nathan Wiederhold, PharmD

; Rosie Bocanegra

; Thomas Patterson, MD, FIDSA

; William Kirkpatrick, MS


12:15 PM

12:15 PM
In Vivo Efficacy of Posaconazole (PSC) against Fusarium solani (FS) with Reduced In Vitro Susceptibility
Destiny Molina

; John Graybill, MD

; Laura Najvar, BS

; Marcos Olivo

; Nathan Wiederhold, PharmD

; Rosie Bocanegra

; Thomas Patterson, MD, FIDSA


12:15 PM
Triple Combination Therapy with Liposomal Amphotericin B (LAMB), Voriconazole (VRC) and Micafungin (MFG) Against Experimental Invasive Pulmonary Aspergillosis (IPA)
E Roilides, MD, PhD

; J Bacher

; Joseph Meletiadis, PhD

; L Greene

; M Cotton

; R Schaufele

; Ruta Petraitiene, MD

; T Walsh, MD

; T Sein

; Vidas Petraitis

CME Credits:

ACPE Credits:

ACPE Number:


See more of: Poster Session